Low-Dose Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-Resistant or Contraindicated Preterm Infants: Three Cases Reports

Background  Although indomethacin (IND) is the standard treatment for hemodynamically significant patent ductus arteriosus (hsPDA) in Japan, it may be associated with renal impairment and gastrointestinal complications. The use of paracetamol for hsPDA closure has recently increased. Unlike IND, par...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumura, Shun, Oshima, Ayumi, Fujinuma, Sumie, Tanaka, Kosuke, Nagano, Nobuhiko, Miyake, Fuyu, Masutani, Satoshi, Tamura, Masanori, Ueda, Keiko, Namba, Fumihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740229/
https://www.ncbi.nlm.nih.gov/pubmed/29276647
http://dx.doi.org/10.1055/s-0037-1615260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740229/
https://www.ncbi.nlm.nih.gov/pubmed/29276647
http://dx.doi.org/10.1055/s-0037-1615260

Ejemplares similares